Finally, the clinical relevance of hs-cTnI and hs-cTnT assay for an early and accurate detection of asymptomatic individuals at higher risk of progressing to symptomatic heart failure (HF) or developing major adverse cardiovascular events (MACE) will be suggested [15,16]. The gene discussed is TNNT2; the disease is heart failure.